216 related articles for article (PubMed ID: 3569007)
1. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
Chin NX; Neu NM; Neu HC
Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
[TBL] [Abstract][Full Text] [Related]
2. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
[TBL] [Abstract][Full Text] [Related]
3. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
4. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus].
Fosse T; David MF; Duluc F
Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260
[TBL] [Abstract][Full Text] [Related]
5. The effect of the combination of erythromycin with new beta-lactam antibiotics against gram-negative aerobic respiratory pathogens.
Nakatomi M; Neu HC
Chemioterapia; 1986 Dec; 5(6):379-84. PubMed ID: 3802298
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
9. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
10. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
11. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
Quentin C; Noury P; Laurent C; Saivin S; Bebear C
Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fleroxacin in combination with other antimicrobial agents.
Neu HC; Chin NX
Am J Med; 1993 Mar; 94(3A):9S-16S. PubMed ID: 8452190
[TBL] [Abstract][Full Text] [Related]
13. Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa.
Wang R; Sun XD; Cai QM
Chin Med J (Engl); 1989 Apr; 102(4):313-8. PubMed ID: 2507247
[TBL] [Abstract][Full Text] [Related]
14. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.
Zhao WH; Hu ZQ; Okubo S; Hara Y; Shimamura T
Antimicrob Agents Chemother; 2001 Jun; 45(6):1737-42. PubMed ID: 11353619
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
Neu HC; Chin NX; Neu NM
Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
[TBL] [Abstract][Full Text] [Related]
17. Synergy of sulbactam and ampicillin against methicillin-resistant staphylococci.
Chin NX; Neu NM; Neu HC
Drugs Exp Clin Res; 1986; 12(12):939-42. PubMed ID: 3032552
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
19. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
Zuravleff JJ; Yu VL; Yee RB
J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
[TBL] [Abstract][Full Text] [Related]
20. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
Kastoris AC; Rafailidis PI; Vouloumanou EK; Gkegkes ID; Falagas ME
Eur J Clin Pharmacol; 2010 Apr; 66(4):359-68. PubMed ID: 20186407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
